1. Home
  2. ATPC vs PYPD Comparison

ATPC vs PYPD Comparison

Compare ATPC & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agape ATP Corporation

ATPC

Agape ATP Corporation

N/A

Current Price

$1.23

Market Cap

63.0M

Sector

Health Care

ML Signal

N/A

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$3.98

Market Cap

57.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATPC
PYPD
Founded
2016
2008
Country
Malaysia
Israel
Employees
N/A
N/A
Industry
Medical/Nursing Services
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.0M
57.8M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
ATPC
PYPD
Price
$1.23
$3.98
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$12.00
AVG Volume (30 Days)
33.4K
82.8K
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,484,905.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
9.66
N/A
52 Week Low
$0.90
$2.30
52 Week High
$2.93
$4.05

Technical Indicators

Market Signals
Indicator
ATPC
PYPD
Relative Strength Index (RSI) 45.59 64.05
Support Level $1.21 $3.72
Resistance Level $1.38 $3.98
Average True Range (ATR) 0.07 0.15
MACD -0.01 0.02
Stochastic Oscillator 18.52 86.00

Price Performance

Historical Comparison
ATPC
PYPD

About ATPC Agape ATP Corporation

Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs. Its segments include: Skin care, health and wellness segment includes the provision of health and wellness products and health solution advisory services; and Green energy segment includes providing renewable energy products, technical solutions, installations and maintenance services. It derives maximum revenue from Skin care, health and wellness segment.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: